Nuzenio

Abcellera Reports

Abcellera Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 14 publisher sources 100/100 entity strength

Latest news

AbCellera Biologics | 8-K: Current report - MoomooMoomoo · Mon, 10 Aug 2026 18:21:59 GMTAbCellera reports positive Phase 2 topline for ABCL635 in menopausal vasomotor symptoms - DealroomDealroom · Mon, 10 Aug 2026 15:36:30 GMTMenopause drug cuts hot flashes in mid-stage trial, company says as shares rise - BNN BloombergBNN Bloomberg · Mon, 10 Aug 2026 14:25:51 GMTAbCellera Announces Positive Phase 2 Top-Line Data for ABCL635 in Clinical Trial - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 14:07:03 GMTdevelopment in the article - MinichartMinichart · Mon, 10 Aug 2026 13:09:00 GMTAbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 12:24:55 GMTAbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - Business WireBusiness Wire · Mon, 10 Aug 2026 11:00:00 GMTAbCellera to Report Phase 2 Menopause Therapy Data - TipRanksTipRanks · Sat, 08 Aug 2026 05:06:27 GMT

Timeline

Mon, 10 Aug 2026 18:21:59 GMTAbCellera Biologics | 8-K: Current report - Moomoo
Mon, 10 Aug 2026 15:36:30 GMTAbCellera reports positive Phase 2 topline for ABCL635 in menopausal vasomotor symptoms - Dealroom
Mon, 10 Aug 2026 14:25:51 GMTMenopause drug cuts hot flashes in mid-stage trial, company says as shares rise - BNN Bloomberg
Mon, 10 Aug 2026 14:07:03 GMTAbCellera Announces Positive Phase 2 Top-Line Data for ABCL635 in Clinical Trial - Kalkine Media
Mon, 10 Aug 2026 13:09:00 GMTdevelopment in the article - Minichart
Mon, 10 Aug 2026 12:24:55 GMTAbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice - Fierce Biotech

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Abcellera Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.